Soluble CD30 Is a New Biomarker to Predict Two-Year Overall Survival of Adult T Cell Leukemia/Lymphoma Patients

Retrovirology - United Kingdom
doi 10.1186/1742-4690-11-s1-p2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy